Open AccessTransplant-Eligible Newly Diagnosed Multiple Myeloma
Author(s) -
Vincent Vidaurri
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615300.45118.b2
Subject(s) - daratumumab , medicine , lenalidomide , clinical endpoint , multiple myeloma , bortezomib , dexamethasone , oncology , surgery , immunofixation , clinical trial , immunology , monoclonal , antibody , monoclonal antibody